Sun Pharmaceutical

Sun Pharma launches LEQSELVI in US for severe hair loss

Sun Pharma launches key alopecia drug in US, experts estimate $200–300 million market potential

Updated: July 15, 2025 14:30 IST

Sun Pharma, pharma industry, Dilip Shanghvi, USFDA, manufacturing, compliance issues, US FDA inspection, R&D spend, revenue, specialty revenue

Sun Pharma steps up USFDA compliance drive: What’s changing at Halol, Mohali and Dadra?

Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra.

July 8, 2025 11:07 IST

3 ‘Buy’ recommendation by Nomura, with up to 28% upside

Nomura issues ‘Buy’ calls on IndusInd Bank, Voltas, and Sun Pharma with up to 28% upside—read the full analysis to…

June 20, 2025 17:06 IST

Is the Halol hurdle too high for Sun Pharma? 4 reasons why Nomura sees limited upside potential

Sun Pharma’s Halol issues limit potential; Nomura sees a 17% upside. Stay updated on regulatory developments at Halol facility.

June 17, 2025 12:34 IST

stocks to watch today, Indian stock market news, Q1 FY26 corporate earnings

From SpiceJet, Adani Ports, Adani Green Energy to Hindustan Zinc – Here are 8 stocks to watch

Stocks to watch today, June 16: GIFT Nifty indicates a flat start for domestic indices. Here are top stocks to…

June 16, 2025 06:40 IST

Sun Pharma shares fall over 4% today. Here’s what’s behind the drop

Sun Pharmaceuticals share price today, May 23: Sun Pharma shares drop 4.77%, hit by weak earnings; explore future market moves!

May 23, 2025 13:38 IST

Gland Pharma, fourth quarter, Q4 results, profit, revenue, EBITDA, dividend, investment, US market, collaborations, manufacturing

Why are pharma stocks falling despite 2,200-point Sensex rally? Nifty Pharma slides 2%

Nifty Pharma share price today, May 12: Pharma stocks fall as Trump plans to slash US drug prices. Discover more…

May 12, 2025 10:49 IST

From TCS, Infosys, Bharti Hexacom to Tata Steel – Here are 8 stocks to watch

Stocks to watch today, April 11: GIFT Nifty was trading up 2.07% to 22,953, which indicates a positive start for…

April 11, 2025 07:13 IST

Motilal Oswal’s top 3 Buy recommendations at this hour

Explore Motilal Oswal’s top stock picks: Sun Pharma, Sapphire Foods, and Bharti Hexacom. Discover growth potential and target prices now!

March 11, 2025 16:37 IST

Sun Pharma share price today, Sun Pharma share news today

Sun Pharma shares slip over 3% after US court’s ruling on LEQSELVI launch

Sun Pharmaceutical shares have delivered impressive gains across multiple time frames, reflecting strong investor interest. Over the past three months,…

Updated: November 4, 2024 11:18 IST

Dilip Sanghvi, Dilip Sanghvi net worth, Dilip Sanghvi lifestyle, Dilip Sanghvi forbes, who is Dilip Sanghvi, Sun Pharma, Dilip Sanghvi Sun Pharma, lifestyle

Who is Indian billionaire Dilip Sanghvi, the man behind Sun Pharma? Know about his Rs 15.65 lakh crore net worth

Founder of Sun Pharma, Shanghvi commands a business empire generating $5.4 billion (approximately Rs 44,971 crore) in revenue.

Updated: December 21, 2023 00:37 IST

Sun Pharma, Bayer, Bayer pharma, cardiac care, heart patients, healthcare news, pharma news,

Sun Pharma Q2 Results: Profit rises 5% to Rs 2375.51 crore, beats estimates

Sun Pharma posted revenue from operations at Rs 12,192.41 crore, up 11.3 per cent as against Rs 10,952.28 crore during…

November 1, 2023 15:49 IST

Sun Pharma, Eye diseases, Eye disorder, dry eyes, trial results, healthcare news, pharma news,

Sun Pharma and Pharmazz Inc. enter into licensing agreement for introducing ischemic stroke drug in India

As per agreement terms, Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide).

September 14, 2023 13:30 IST

Sun Pharma, fourth quarter, Q4FY23 results, profit, revenue, dividend

Sun Pharma acquires three brands from Aksigen to strengthen its anti-inflammatory portfolio

According to IQVIA data MAT Nov 2022, India’s overall market of proteolytic enzyme for healing, pain and edema is around…

January 30, 2023 13:00 IST

Dr. Reddy's, Dr Reddy's labs, Difluprednate Ophthalmic Emulsion, eye drops, eye care, health news, pharma news,

Pharma majors Glenmark, Sun Pharma and Dr Reddy’s recall products in United States

In the last financial year, India’s pharma exports stood at around USD 24.62 billion with the US, the UK, South…

August 15, 2022 19:06 IST

Sun Pharmaceuticals rating: Buy | Specialty sales boost prospects

Quarter performance beat estimates; FY23/24e EPS up 1/3%; target price revised to Rs 1,089; ‘Buy’ retained.

August 2, 2022 01:30 IST

Sun Pharma, Glenmark, USFDA, health news, pharma news,

Sun Pharma, Glenmark recall products due to manufacturing issues in United States

Reportedly, the Mumbai-based drug major is recalling the affected lot due to “water leakage” leading to deviation from current good…

July 25, 2022 18:08 IST

FE Pharma Summit, Sun Pharmaceutical, Zydus Cadila, Glenmark Pharmaceuticals, Biocon, DCGI

FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges

The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders…

Updated: March 23, 2022 15:05 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

DA Hike 2025: Central government employees, pensioners to get 3% hike from September — last increase under 7th Pay Commission

Last DA hike in 7th Pay Commission: Central govt employees set for salary boost ahead of Diwali – Check likely increase

Canada, French-speaking foreigners, Express Entry draw results, released, announced, French language proficiency, permanent residency

Canada invites French speakers to apply for permanent residence

‘We just have moments on occasion’: Trump defends US-India ties amid trade dispute

World News34 min ago

US President Donald Trump assured that the relationship between India and the United States is special and there is no need to worry about occasional disagreements. However, he expressed disappointment over India’s purchase of Russian oil and high tariffs.

View all shorts